share_log

Guggenheim Initiates Coverage On Cidara Therapeutics With Buy Rating, Announces Price Target of $33

Guggenheim Initiates Coverage On Cidara Therapeutics With Buy Rating, Announces Price Target of $33

古根海姆開始覆蓋cidara therapeutics,並給予買入評級,宣佈目標股價爲33美元
Benzinga ·  2024/11/08 19:31  · 評級/大行評級

Guggenheim analyst Seamus Fernandez initiates coverage on Cidara Therapeutics (NASDAQ:CDTX) with a Buy rating and announces Price Target of $33.

古根海姆分析師Seamus Fernandez發起對cidara therapeutics(納斯達克:CDTX)的覆蓋,給予買入評級,並宣佈目標股價爲33美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論